Science to practice: Can semiquantitative contrast-enhanced CT be used to evaluate hepatic fibrosis?

Jacob Sosna*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations

Abstract

Contrast material-enhanced computed tomographic (CT) uptake of conventional and macromolecular iodine-based contrast agents may be used as a semiquantitative marker of liver fibrosis.

Original languageAmerican English
Pages (from-to)1-2
Number of pages2
JournalRadiology
Volume266
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Science to practice: Can semiquantitative contrast-enhanced CT be used to evaluate hepatic fibrosis?'. Together they form a unique fingerprint.

Cite this